Table of Contents Introduction Dipeptidyl Peptidase-4 (DPP-4) Inhibitors , commonly referred to as gliptins , are oral antidiabetic drugs that enhance the action of incretin hormones , especially GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic peptide)
Patients with variants in iron metabolism genes (like HFE) or zinc transporters may benefit from more aggressive supplementation protocols designed specifically for their genetic predisposition
Why it matters You need to know the cost of onboarding and follow-ups before committing to monitored care
Klinic is committed to providing remote weight management, offering medications like Wegovy, Oral Wegovy, Zepbound, and Foundayo, specifically designed and approved for weight loss
Physiology Journals Baggio LL, Drucker DJ
Overall prescribing trends The study found that 2,185,238 patients were prescribed a GLP-1 RA between January 2019 and December 2025, with 11,194,909 total prescriptions during this period